Novel discovery links anti-cancer drugs to muscle repair
OTTAWA, October 16, 2012 – Few drugs are available to treat muscle injury, muscle wasting and genetic disorders causing muscle degeneration, such as Duchenne muscular dystrophy. A compelling discovery that may change this was made recently by a research group led by Dr. Robert Korneluk, distinguished professor at University of Ottawa's Faculty of Medicine and founder of the CHEO Research Institute's Apoptosis Research Centre, was reported today in Science Signaling.
"We know of five pharmaceutical companies pursuing phase one clinical trials with specific drugs to treat ...






